SCHEMBL6140902

SCHEMBL6140902

O=C([AsH]C(Cc1ccc2cc(-c3c(Cl)cccc3Cl)ccc2c1)C(=O)O)c1c(Cl)cccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 10/20 0.44
ITGAV P06756 2/20 0.44
FABP3 P05413 1/20 0.38
FABP4 P15090 1/20 0.38
FABP5 Q01469 1/20 0.38
ITGA4 P13612 8/20 0.38
ITGB7 P26010 6/20 0.38
FFAR1 O14842 2/20 0.38
MME P08473 1/20 0.35
ACE P12821 1/20 0.35
CPA1 P15085 1/20 0.35
ACE2 Q9BYF1 1/20 0.35
JAK2 O60674 1/20 0.35
TYK2 P29597 1/20 0.35
FFAR4 Q5NUL3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6142370 0.83 ITGB1 (0.66) ITGB1ITGAVITGA4ITGB7FFAR1
SCHEMBL3319945 0.78 GRIA2 (0.49)
SCHEMBL6151313 0.77 ITGB1 (0.52) ITGB1ITGAVITGA4ITGB7
SCHEMBL3314241 0.77 ITGB1 (0.70) ITGB1ITGAVITGA4ITGB7
Hydrochloric Acid SCHEMBL3313215 0.77 GRIA2 (0.48)
SCHEMBL6140931 0.75 ITGB1 (0.54) ITGB1ITGAVITGA4ITGB7
SCHEMBL4627756 0.74 ITGB1 (0.54) ITGB1ITGAVITGA4ITGB7MME
SCHEMBL6140590 0.73 ITGB1 (0.56) ITGB1ITGAVFABP4ITGA4ITGB7
SCHEMBL4625235 0.70 ITGB1 (0.56) ITGB1ITGAVITGA4ITGB7
SCHEMBL3315065 0.70 FABP3 (0.42) FABP3FABP4FABP5FFAR1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501801-A1 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS UCB, S.A. (BE) 2005-02-02 EP disclosed
WO-2003093237-A1 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS UCB, S.A. (BE) 2003-11-13 WO disclosed